Authors
Latest:
First-in-Class Oral Therapy Is Approved for Uncomplicated Urinary Tract InfectionThis novel mechanism of action provides an alternative therapy for patients with recurrence or those who may not tolerate current first-line therapies.
Latest:
FDA lifts some restrictions on diabetes drug AvandiaReevaluation of RECORD trial data fails to uncover elevated cardiovascular risk.
Latest:
Teachable moments: Take your best shotWhen it comes to knowledge of medications and their actions, pharmacists have it way over most physicians. For the sake of the patient, you have to speak up, whether the doc likes it or not.
Latest:
The hydrocodone questionAsking whether hydrocodone should be rescheduled is only the beginning.
Latest:
Should you establish a medical marijuana dispensary?If your inner entrepreneur is hollering to get out, maybe you should go for it.
Latest:
A Pharmacist Makes the Case Against Legalizing MarijuanaThe legalization of marijuana has consequences.
Latest:
Pharmacists Provide Harm Reduction Services to Patients With Substance Use DisorderOur whole country needs to do better in providing harm reduction services, including naloxone and syringe service programs.
Latest:
It's Time for Pharmacists to Carve Out a New RoleSpecialty pharmaceuticals will have a growing impact on pharmacists. Here’s how it could change your role.
Latest:
Patients and Herbal SupplementsYour patients are using herbal products, but do you know enough about them?
Latest:
Hold the phoneHow can an independent pharmacy survive in the face of competition from the mega-chains? Here's a clue.
Latest:
Barriers Coming Down for Complex Generic Drug ProductsThis year may mark a dramatic difference in the development and approval of complex generic drug products.
Latest:
Apalutimide for Prostate Cancer: What to KnowFDA approves apalutamide for castration-resistant prostate cancer.
Latest:
Apalutimide for Prostate Cancer: What to KnowFDA approves apalutamide for castration-resistant prostate cancer.
Latest:
Diabetes Management and the Promise of TelemedicineCould telemedicine be the answer to diabetes management problems?
Latest:
Fixing a Broken System with TechnologyTechnology can help patients who need specialty pharmacy medications get them faster by streamlining the processes involved.
Latest:
Making the Case for Regulated MarijuanaPharmacists urged to support controls to the marijuana market but oppose criminalization.
Latest:
Pediatric Patients Present Unique Challenges to PharmacistsBoard-certified pharmacists are better prepared to deal with pediatric patients than others. Here’s why.
Latest:
Betrixaban for Prophylaxis of Venous ThromboembolismBetrixaban has been approved by the FDA for patients at risk for thromboembolisms.
Latest:
Betrixaban for Prophylaxis of Venous ThromboembolismBetrixaban has been approved by the FDA for patients at risk for thromboembolisms.
Latest:
Four Things Pharmacists Need to Know About Specialty PharmacyHow independent pharmacies can use specialty medications to increase profits and help their patients.
Latest:
Let’s Do This! A Call to Action for Test to Treat in PharmacyPresident Biden’s recent State of the Union address included a pharmacy Test to Treat iniativie for COVID-19.
Latest:
What Community Pharmacists Want-And How You Can Get ItNCPA found three things that pharmacists desperately want changed. Here’s how they’re going to do it.
Latest:
Pharmacists, It’s Time to Speak UpHealthcare is at a dangerous place right now-but pharmacists can be the ones to help save it.
Latest:
Critical Care Board Certification Gains MomentumIf you’ve never thought about becoming certified, now is a great time to do it.
Latest:
The Smart Technology That Will Change Diabetes CareGPS-based dietary prompts, continuous glucose monitors among the devices poised to revolutionize diabetes treatment and patient management.
Latest:
How Pharmacists Can Tackle the Leading Cause of DeathInterested in cardiology? Here’s why you should consider becoming extra training and certification.
Latest:
Why Pharmacists Need to Change Their AttitudeThe opioid epidemic requires that all healthcare professionals-pharmacists included-re-examine how they approach pain patients.
Latest:
New Drug Review: SpravatoBoth responder and remitter patients experienced a statistically significant longer time to relapse with esketamine compared to the placebo
